𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Homotypic and heterotypic antibody response in infants to adenovirus vaccine

✍ Scribed by J. van der Veen; D. J. van Zaane; M. A. J. Sprangers; C. F. A. Heyen


Publisher
Springer Vienna
Year
1967
Tongue
English
Weight
764 KB
Volume
21
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Homotypic and heterotypic serum neutrali
✍ Gorrell, Rebecca J.; Bishop, Ruth F. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 149 KB

Worldwide trials of rotavirus vaccines are currently in progress, but the basis of cross-reactive immunity between rotavirus serotypes is yet to be elucidated. The involvement of the outer capsid proteins, VP7 and VP4, in the production of cross-reactive neutralizing antibody (N-Ab) is unclear, and

Homotypic and heterotypic IgG and IgM an
✍ Hale, A. D.; Lewis, D. C.; Jiang, X.; Brown, D. W. G. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 119 KB πŸ‘ 2 views

Antibody responses to recombinant Norwalk (rNV) and Mexico (rMXV) viral capsid proteins were studied in 39 adults involved in outbreaks of gastroenteritis associated with genogroup 2 small round structured viruses (SRSVs). Nineteen individuals were involved in outbreaks associated with MXV-like stra

The prevalence of antibodies to adenovir
✍ Rajendra Pilankatta; Tanu Chawla; Navin Khanna; Sathyamangalam Swaminathan πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 1 views

## Abstract In vivo gene delivery using human adenovirus serotype 5 (AdV5) vectors is being explored for vaccination purposes. The presence of anti‐AdV5 antibodies in human serum arising from natural exposure to AdV5 can interfere potentially with and compromise the efficacy of rAdV5‐based vaccine

Antibody response to influenza vaccine i
✍ Shigeki Nabeshima; Kenichiro Kashiwagi; Masayuki Murata; Yoko Kanamoto; Norihiro πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 115 KB

## Abstract Fifty seven hospital workers received influenza vaccine in November 2003, and the serum HI antibody titer was determined before, 2 and 4 weeks after the vaccination. Thirty seven were vaccinated in November, 2002 consecutively (the repeated vaccination group), and the remaining 20 had n